defendant carlsbad technology,cti appeals from the decision of the united states district court for the central district of california remanding the case to state court.hif bio,yung shin pharms.indus,order.the remand order was entered in response to a motion to dismiss brought by defendant cti.id.at.because we lack jurisdiction to review this appeal,we dismiss.
the plaintiffs alleged the following facts,which we accept as true for purposes of this appeal,in their first amended complaint fac.
in,park park and chun chun,two researchers affiliated with a korean university,began to investigate the effect of the chemical compound on a protein complex known as.a component of is expressed in human tumors,and park and chun hypothesized that could be used to inhibit the activity of,which would have the effect of suppressing angiogenesis,that is,the growth of blood vessels into animal tumors,and thereby kill the tumor by starving it of oxygen and nutrients.fac.
between and,park and chun conducted a series of laboratory experiments that confirmed that in fact inhibits activity in vitro,that is,in test tube experiments and in vivo,that is,in live laboratory animals.id.park and chun filed a korean patent application disclosing their invention,including the novel,application of and submitted the results of their experiments in papers to two academic journals,which subsequently accepted and published the papers.id.
during this time period,park contacted and exchanged several emails with defendant teng teng.park contacted defendant teng because of his prior role in the synthesis and development of,his general familiarity with the compound,and his relationship with defendant yung shin pharmaceuticals industrial,yung shin,a major supplier of.id.defendant teng supplied park with four batches of to be used in the experiments.park disclosed the results of his study and sent to defendant teng a draft manuscript of the in vitro paper and the experimental data from the in vivo experiments.park also suggested that defendant teng and defendant lee,the president of defendant yung shin,could be of the in vitro paper.id.unknown to park and chun,defendants rocky tsao and fish richardson collectively patent attorneys filed patent applications covering the novel,properties of and naming defendants lee and teng as the inventors.id.in march,defendant yung shin filed a pct application claiming priority to the provisional application.id.
in july,park and chun assigned all of their rights relating to to plaintiff bizbiotech.plaintiff bizbiotech attempted to negotiate a joint venture with defendants teng,lee,and yung shin during the negotiations,plaintiff bizbiotech disclosed its patent protection strategy and business plans.id.the defendants involved in the negotiations did not reveal their own patent applications to the plaintiffs.id.in february,plaintiff bizbiotech assigned all of its rights with respect to to plaintiff hif bio,hif.
plaintiffs bizbiotech and hif assert that they hold all rights with respect to the invention and application of as an,agent,including several patent applications filed between april and june naming park and chun as the inventors.id.the plaintiffs also assert that defendant cti agreed to work with defendants yung shin,lee,and teng to further develop,commercialize,sell and market and its analogues as,drugs in the united states and abroad.id.
in september,plaintiffs hif and bizbiotech filed a complaint against defendants yung shin,yung zip chem,yung zip,lee,teng,cti,and patent attorneys in los angeles superior court.in november,defendant cti removed the action to the united states district court for the central district of california.in march,the plaintiffs filed their first amended complaint,asserting twelve causes of action.
the first and second causes of action seek a declaratory judgment for ownership and inventorship,respectively,of the invention.fac.the third cause of action asserts violations of the racketeer influenced and corrupt organizations act rico.fac.the remaining nine causes of action are based respectively on slander of title,id.conversion,id.actual and constructive fraud,id.intentional interference with contractual relations and prospective economic advantage,id.negligent interference with contractual relations and prospective economic advantage,id.breach of implied contract,id.unfair competition and fraudulent business practices,id.unjust trust,id.and permanent injunction,id.
the defendants filed various motions to dismiss and to strike.of pertinence here,defendant cti moved to dismiss the plaintiffs first amended complaint based on federal rule of civil procedure b and.the district court dismissed the rico claim finding that the plaintiffs have not adequately alleged a pattern of racketeering.order,slip op.at.in addition,the district court declined supplemental jurisdiction over the rights of inventorship and ownership of inventions claims,which it found were state law claims,and also declined supplemental jurisdiction over the plaintiffs nine other state claims.id.at.having declined supplemental jurisdiction over the state claims,the district court remanded the case to state court.id.
defendant cti filed a timely notice of appeal with this court 
we have stated that w hether this court has jurisdiction over an appeal taken from a district court judgment is a question of law which we address in the first instance.thompson microsoft,quoting pause tech.llc tivo.whether the district court possessed jurisdiction is also a question of law that this court reviews without deference.dehne united states,this court reviews jurisdiction,a question of law,de novo.citation omitted see elder holloway,d q uestion s of law must be resolved de novo on appeal.teva pharms.usa,novartis pharms,declaratory judgment action voda cordis,supplemental jurisdiction see grable sons metal,darue eng g,d federal question jurisdiction in removal context.
title reaffirms that the exercise of supplemental jurisdiction is within the discretion of the district court.mars,nippon conlux,see also city of chicago int l coll.of surgeons,d stating that supplemental jurisdiction statute codifies the principle that pendent jurisdiction is a doctrine of discretion,not of plaintiff right,and that district courts can decline to exercise jurisdiction over pendent claims for a number of valid reasons quoting united mine workers of am.gibbs,d.a district court discretion,however,is not unfettered and is subject to review for an abuse of discretion.voda,at.
defendant cti asserts on appeal that the district court remand order was improper because the plaintiffs remanded claims raise a substantial question of federal patent.the plaintiffs assert that the district court remand order was proper because their claims are based solely on state law and do not arise under the federal patent laws.we dispose of this appeal,however,on a threshold this court has appellate jurisdiction to review the district court remand order.
the supreme court has stated that every federal appellate court has a special obligation to satisfy itself of its own jurisdiction even though the parties are prepared to concede it.bender williamsport area sch,d citation and internal quotation marks omitted see,safetcare,smith nicholson.here,because defendant cti appeals from a remand order,we must determine whether d bars this court appellate jurisdiction.powerex reliant energy,d the authority of appellate courts to review orders remanding removed cases to state court is substantially limited by d.for the following reasons,we find that d bars this court review of the remand order.
title d provides with an exception for civil rights cases removed from state court pursuant to that a n order remanding a case to the state court from which it was removed is not reviewable on appeal or otherwise.while the language of this statute on its face appears to preclude review,the supreme court has interpreted d to cover less than its words alone suggest.powerex.at.
in the seminal case of thermtron products,hermansdorfer,d,the supreme court held that appellate courts are not barred by d from reviewing a district court remand order